June and July have been very busy months in the diabetes world...

Exciting findings from the largest diabetes meeting of the year, the American Diabetes Association’s annual Scientific Sessions.

Allergan’s LAP-BAND, an implantable weight-loss device. Following an FDA advisory committee ’s recommendation last December (see New Now Next in diaTribe #28), the FDA...

We were heartened this year by World Diabetes Day, which officially recognizes the growing epidemics of diabetes, diabetes complications, and obesity. Every year on...

Last week, in a surprise and, in our view, disappointing move, the FDA decided to not approve Bydureon, a once-weekly GLP-1 agonist, for use in the United States despite...

Imagine dreaming about waking up alive inside a body bag. Vietnam veteran Urban Miyares did, but it wasn’t exactly a dream...

Asante’s Pearl insulin pump has received FDA clearance and CE Mark approval. In welcome news, Asante Solutions received FDA clearance for its new Pearl insulin pump in...

Even though exercise and weight loss have been shown to reduce a person’s chance of developing type 2 diabetes, healthcare providers have not traditionally reimbursed...

Stellar diabetes experts descend on San Francisco for the ADA’s 57th Annual Advanced Postgraduate Course.

The LAP-BAND is a weight-loss device that is implanted around the top of the stomach using minimally invasive (laparoscopic) surgery, which effectively creates a small...

Kerri Morrone Sparling gives her take on the pros and cons of CGM.

Puzzled by the recent FDA decisions? Dr. Sanjay Kaul discusses the regulatory environment for diabetes and obesity medications.

No doubt, you have in all likelihood heard about the FDA’s decision to restrict access to Avandia, based on data suggesting its use is associated with an elevated risk...

An evolutionary step for Paradigm pumpers – see Dana Lewis’s take on Medtronic’s new pump/CGM integrated platform the Paradigm REAL-Time Revel system.

We discuss the “motivated patient” and highlights from the American Association of Diabetes Educators’ annual meeting as well as big changes here at diaTribe …

While we’re willing to bet that most people with diabetes think that blood glucose meters are an important tool, there is surprisingly little scientific evidence...

The FDA just approved Medtronic’s latest insulin pump, called the MiniMed Paradigm REAL-Time Revel System – this is Medtronic’s first new pump platform to be approved in...

A thorough review and “how-to” on the drug Symlin (Amylin’s pramlintide).

Earlier this week, the FDA chose not to approve the weight-loss drug Qnexa. Qnexa is a combination of two currently approved drugs: phentermine, which is approved for...

Our top takeaways from the European Association for the Study of Diabetes meeting in Stockholm, and The Obesity Society meeting in San Diego.